First HIV Drug Approved By FDA Turns 30

This past week, March 19th to be exact was the 30th anniversary of the day when FDA approved AZT (Zidovudine) brand name Retrovir, the first drug to treat HIV/AIDS. This was 6 years after the first AIDS cases were reported to CDC in June 5th 1981 MMWR report, after cases were reported among healthy gay…

Continue Reading →

To Save On Drug Costs, Insurer Wants To Steer You To ‘Preferred’ Pharmacies

By Pauline Bartolone March 9, 2017 One of California’s largest insurers has proposed a change in the benefits of commercial plans next year that would require consumers to pay more for drugs at pharmacies outside an established network. Blue Shield of California wants to create “a tiered pharmacy network” in its 2018 small- and large-group…

Continue Reading →

Trump, Dems Look For Common Ground On Drug Prices

By Sarah Jane Tribble For years, congressional Democrats have tried to pass legislation to allow Medicare to negotiate prescription drug prices for millions of beneficiaries. Now, they believe they have a not-so-secret weapon: President Donald Trump. On Wednesday, U.S. Reps. Elijah Cummings (D-Md.) and Peter Welch (D-Vt.) met privately for about an hour with Trump…

Continue Reading →

Five Ways The GOP Health Bill Would Reverse Course From The ACA

By Julie Rovner After literally years of promises, House Republicans finally have a bill they say will “repeal and replace” the Affordable Care Act. Some conservative Republicans have derided the new proposal — the American Health Care Act — calling it “Obamacare Lite.” It keeps intact some of the more popular features of the ACA,…

Continue Reading →

Patient Advocacy Groups Rake In Donations From Pharma

By Emily Kopp March 1, 2017 High-profile advocacy groups for patients with cancer, Alzheimer’s, HIV and other diseases almost always accept funding from pharmaceutical firms, and many fail to report any contributions, new research shows. At least 83 percent of the nation’s 104 largest patient advocacy groups take contributions from the drug, medical device and…

Continue Reading →

State Fires Contractor After Problems Put California HIV Patients At Risk

By Anna Gorman March 2, 2017 California’s public health department Wednesday fired the contractor responsible for enrolling patients in a state-run AIDS program, saying its poor performance threatened enrollees’ access to life-saving medications. The state announced it had terminated the contract with A.J. Boggs & Company because of several “material breaches,” including the failure to…

Continue Reading →

Instead Of Trashing A $600 EpiPen, Some Patients Get A Refill

By Shefali Luthra The concern over soaring prescription drug prices continues to dominate headlines, attracting scrutiny from Capitol Hill and President Donald Trump, who said during a January press conference that the industry was “getting away with murder.” But some doctors — frustrated by what they see as unreasonable price tags and political stagnation —…

Continue Reading →

MichRx HIV Pharmacy Online Certification Latest AD

We have a new online AD for our HIV Pharmacy Certification Program watch it here

Continue Reading →

Tackling Patients’ Social Problems Can Cut Health Costs

By Sarah Varney January 23, 2017 HOUSTON — Donning a protective gown, rubber gloves and a face mask, Dayna Gurley looks like she’s heading into surgery. But Gurley is a medical social worker charged with figuring out why her client, a man who uses more health care services than almost anyone else in Houston, has…

Continue Reading →

Crucial California HIV Program In Disarray After Contract Switch

By Anna Gorman January 13, 2017 A change in contractors for a state-run AIDS program has resulted in enrollment delays and left some patients unable to get necessary medications and timely medical care, according to legislators and nonprofit organizations across California. The AIDS Drug Assistance Program, which helps more than 30,000 low-income HIV and AIDS…

Continue Reading →

Page 1 of 20